Research Papers

25 of 118 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Machine learning versus conventional clinical methods in guiding management of heart failure patients-a systematic revi…
Bazoukis G; Stavrakis S; Zhou J; Bollepalli SC; Tse G; Zhang Q; Singh JP; Armoundas AA.
Heart Fail Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Heart failure and COVID-19.
Bader F; Manla Y; Atallah B; Starling RC.
Heart Fail Rev (Unknown)
Published: 2021
1/6 Transparent
Right ventricular phenotype, function, and failure: a journey from evolution to clinics.
Taverne YJHJ; Sadeghi A; Bartelds B; Bogers AJJC; Merkus D.
Heart Fail Rev (Unknown)
Published: 2021
1/6 Transparent
The role of non-invasive devices for the telemonitoring of heart failure patients.
Faragli A; Abawi D; Quinn C; Cvetkovic M; Schlabs T; Tahirovic E; Düngen HD; Pieske B; Kelle S; Edelmann F; Alogna A.
Heart Fail Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis.
Bosch L; de Haan JJ; Bastemeijer M; van der Burg J; van der Worp E; Wesseling M; Viola M; Odille C; El Azzouzi H; Pasterkamp G; Sluijter JPG; Wever KE; de Jager SCA.
Heart Fail Rev (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabet…
Täger T; Atar D; Agewall S; Katus HA; Grundtvig M; Cleland JGF; Clark AL; Fröhlich H; Frankenstein L.
Heart Fail Rev (Unknown)
Published: 2021
4/6 Transparent
Registered Funding Declared
The Elabela-APJ axis: a promising therapeutic target for heart failure.
Ma Z; Song JJ; Martin S; Yang XC; Zhong JC.
Heart Fail Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis.
Wobbe B; Wagner J; Szabó DK; Rostás I; Farkas N; Garami A; Balaskó M; Hartmann P; Solymár M; Tenk J; Ottóffy M; Nagy A; Habon T; Hegyi P; Czopf L.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure.
Dutka M; Bobiński R; Ulman-Włodarz I; Hajduga M; Bujok J; Pająk C; Ćwiertnia M.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors.
Margonato D; Galati G; Mazzetti S; Cannistraci R; Perseghin G; Margonato A; Mortara A.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational stu…
Triposkiadis F; Starling RC; Xanthopoulos A; Butler J; Boudoulas H.
Heart Fail Rev (Unknown)
Published: 2020
1/6 Transparent
Various aspects of inflammation in heart failure.
Dutka M; Bobiński R; Ulman-Włodarz I; Hajduga M; Bujok J; Pająk C; Ćwiertnia M.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Correction to: Structural and myocardial dysfunction in heart failure beyond ejection fraction.
Severino P; Maestrini V; Mariani MV; Birtolo LI; Scarpati R; Mancone M; Fedele F.
Heart Fail Rev (Unknown)
Published: 2020
New perspectives and future directions in the treatment of heart failure.
Pellicori P; Khan MJI; Graham FJ; Cleland JGF.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials.
Zhu Y; Gu X; Xu C.
Heart Fail Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Authors' response to the letter: Takotsubo syndrome: a neurocardiac syndrome inside the autonomic nervous system.
Borodzicz S; Czarzasta K; Opolski G; Cudnoch-Jędrzejewska A.
Heart Fail Rev (Unknown)
Published: 2019
Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life…
Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA.
Heart Fail Rev (Unknown)
Published: 2019
3/6 Transparent
Registered Funding Declared
The relevance of microRNA in post-infarction left ventricular remodelling and heart failure.
Dutka M; Bobiński R; Korbecki J.
Heart Fail Rev (Unknown)
Published: 2019
1/6 Transparent
Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved eject…
Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN.
Heart Fail Rev (Unknown)
Published: 2019
2/6 Transparent
Registered
Current animal models for the study of congestion in heart failure: an overview.
Cops J; Haesen S; De Moor B; Mullens W; Hansen D.
Heart Fail Rev (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Practical guidance on the use of sacubitril/valsartan for heart failure.
Sauer AJ; Cole R; Jensen BC; Pal J; Sharma N; Yehya A; Vader J.
Heart Fail Rev (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Protective role of beta-blockers in chemotherapy-induced cardiotoxicity-a systematic review and meta-analysis of carved…
Huang S; Zhao Q; Yang ZG; Diao KY; He Y; Shi K; Shen MT; Fu H; Guo YK.
Heart Fail Rev (Unknown)
Published: 2019
3/6 Transparent
Registered Funding Declared
Structural and functional abnormalities in iron-depleted heart.
Kobak KA; Radwańska M; Dzięgała M; Kasztura M; Josiak K; Banasiak W; Ponikowski P; Jankowska EA.
Heart Fail Rev (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
Vinke P; Jansen SM; Witkamp RF; van Norren K.
Heart Fail Rev (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Infectious myocarditis: the role of the cardiac vasculature.
Woudstra L; Juffermans LJM; van Rossum AC; Niessen HWM; Krijnen PAJ.
Heart Fail Rev (Unknown)
Published: 2018
1/6 Transparent